This alludes to the hypothesis that COVID-19-mediated dysfunctional activity and degradation of BMAL1/ARNTL can mediate chronic microglial-inflammatory responses and neuronal ferroptosis-mediated demise. The gene discussed is BMAL1; the disease is COVID-19.